Replay conference
COVID-19: Advances and Remaining Challenges
Paris, September 29th - October 1st, 2021
Wednesday, September 29, 2021
Opening session

Stewart Cole
CEO, Institut Pasteur

Introduction

Claire Giry
French minister of Higher Education, Research and Innovation

Director General of Research and Innovation who is representing French minister of Higher Education, Research and Innovation, Frédérique Vidal

Stewart Cole
CEO, Institut Pasteur

Marion Koopmans
Erasmus Medical Center, The Netherlands

The quest to understand the origins of SARS-CoV-2

Stewart Cole
CEO, Institut Pasteur

Soumya Swaminathan
Executive Director, Chief Scientist, World Health Organisation

Allocution

Thursday, September 30, 2021
Viral evolution and perspectives

Neil Ferguson
Imperial College, London, United Kingdom

Assessing variant-specific changes in epidemiological phenotype and vaccine efficacy

Ran Balicer
Clalit Research Institute, Israel

Population-based studies of vaccine effectiveness and tolerance in Israël

Emma Hodcroft
Bern University, Switzerland

Real-time to Real-life: Phylogenetics & SARS-CoV-2 Variant Tracking

Marion Koopmans
Erasmus Medical Center, The Netherlands

Viral entry and replication/neutralisation

Olivier Schwartz
Institut Pasteur, France

Delta variant replication and antiviral immune responses

Wendy Barclay
Imperial College London, United Kingdom

Evolution of the spike cleavage site in SARS-CoV-2 enhances airborne transmission

Sai Li
Tsinghua University, China

In-situ architecture and neutralization mechanism of SARS-CoV-2

Viral persistence and long Covid

Mayssam Nehme
Hôpitaux Universitaires de Genève, Switzerland

Clinical presentation of long Covid

Aaron Ring
Yale University, United States

Long Covid and autoantibodies

Andrew Chris Yang
Stanford University, United States

Inflammation and dysregulation of brain cell types in severe COVID-19 : links to long-term symptoms

Patient management and future treatments

Florence Ader
Inserm, France

Choosing an antiviral treatment for SARS-CoV-2 pneumonia

Peter Horby
Oxford University, United Kingdom

Immunomodulatory therapy for COVID-19 and other severe viral pneumonias

Jesús Rodríguez-Baño
Former President of ECCMID

Future therapeutical strategies

Friday, October 1, 2021
Evaluation of impact of interventions

Jeffrey Townsend
Yale University, United States

Optimal COVID-19 quarantine and testing strategies

Christophe Fraser
Oxford University, United Kingdom

Digital contact tracing: conception, development and evaluation

Susan Michie
University College London, United Kingdom

Applying behavioural science to understanding Covid-19 protective behaviours

Children and SARS-CoV-2 transmission and control

Arnaud Fontanet
Institut Pasteur, France

Children susceptibility and infectiousness

Tamsin Ford
University of Cambridge, United Kingdom

COVID impact on physical and mental health of children

Vittoria Colizza
Inserm, France

Impact of self-testing and vaccination of children on schools closing

Vaccine regimens and effectiveness

Galit Alter
Harvard-T.H. Chan, United States

Using Systems Serology to define correlates of immunity to SARS-CoV-2

Simon Cauchemez
Institut Pasteur, France

Anticipating the impact of vaccines on epidemic dynamics

Brigitte Autran
Inserm, France

Available and future vaccines

Why and how should we get the planet vaccinated?

Derek Smith
Cambridge University, United Kingdom

Antigenic variation of SARS-CoV-2 viruses and vaccine strain update strategies

Melanie Saville
CEPI, France

Challenges of developing, producing and delivering COVID-19 vaccines to the world

Derek Smith
Cambridge University, United Kingdom

Salim Abdool Karim
CAPRISA, South Africa

Global SARS-CoV-2 vaccination: Challenges and Prospects

Closing lecture

Shane Crotty
La Jolla Institute for Immunology, United States

Adaptive immunity and memory to SARS-CoV-2 infection or COVID-19 RNA vaccines

Closing address

Rochelle Walensky
Director, US CDC, United States

Closing address

Closing words

Olivier Véran
French Minister for Solidarity and Health

Allocution

Translation

Yazdan Yazdanpanah
ANRS | Maladies infectieuses émergentes / Inserm, France

Closing Remarks

 

Persistance-webSoft
congresoft.fr
plateforme dédiée aux manifestations
Tel. : 01 84 17 20 55 / 06 89 19 34 06
E-mail : contact@congresoft.fr
La première plateforme Française de gestion de manifestations regroupant la billeterie, la gestion des hébergements, une boutique en ligne, la gestion des surfaces d'exposition et la gestion complète du programme scientifique.
Organisation de Congrès, manifestations, Séminiaires, Colloques